Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -2.88% shed 1.39% to $110.82 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.52% rising 0.59% to 14,893.75 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.45% falling 0.56% to 35,911.81. This was the stock's fourth consecutive day of losses. Novavax Inc. closed $220.86 below its 52-week high ($331.68), which the company achieved on February 9th.
The stock underperformed when compared to some of its competitors Friday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL +2.15% rose 2.36% to $23.87, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -2.10% rose 7.33% to $2.05, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.72% rose 3.09% to $33.74. Trading volume (9.8 M) eclipsed its 50-day average volume of 5.9 M.